RecruitingNCT04570163
Berlin Registry of Right Heart Interventions
Sponsor
Charite University, Berlin, Germany
Enrollment
200 participants
Start Date
Jun 16, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The present study evaluates patients after interventional therapy of valvular diseases of the right heart. Follow-up examinations include medical history taking, laboratory measurements and an echo. The aim is to assess the different interventional therapies and their impact on patient's outcome.
Eligibility
Min Age: 18 YearsMax Age: 120 Years
Inclusion Criteria3
- Patients with planned or recent valve interventions of the right heart (tricuspid regurgitation/ stenosis, pulmonary regurgitation/ stenosis)
- \>18 years
- Written, documented consent
Exclusion Criteria3
- Patients in care or unable to consent
- Patients who are unable to comply with follow-up examinations
- Patients who are detained in an institution
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEInterventional therapy mainly of tricuspid regurgitation (TriClip, Cardioband)
Catheter-based therapy of valve diseases of the right heart with various devices (e. g. TriClip, Cardioband).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04570163
Related Trials
TriClip Japan Post-Approval Study
NCT075096581 location
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
NCT0409714579 locations
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
NCT0584828411 locations
Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults.
NCT074641061 location
TTVR Early Feasibility Study
NCT0443306520 locations